Methodist Estabrook Cancer Center /ID# 216910 — Omaha, Nebraska

Methodist Estabrook Cancer Center /ID# 216910 is a clinical research site located in Omaha, Nebraska, United States 68114-4108.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Methodist Estabrook Cancer Center /ID# 216910 has participated in 1 clinical trials.

Therapeutic areas: Non Small Cell Lung Cancer, Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Methodist Estabrook Cancer Center /ID# 216910?

Methodist Estabrook Cancer Center /ID# 216910 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Methodist Estabrook Cancer Center /ID# 216910 conducted?

Methodist Estabrook Cancer Center /ID# 216910 has 1 clinical trials on record. Their work covers Non Small Cell Lung Cancer, Cancer.

Is Methodist Estabrook Cancer Center /ID# 216910 accredited by Crixeo Health?

Methodist Estabrook Cancer Center /ID# 216910 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Methodist Estabrook Cancer Center /ID# 216910?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.